SEARCH

SEARCH BY CITATION

References

  • Boelaert M, Meheus F, Sanchez A et al. (2009) The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health, 14, 639644.
  • Das VN, Pandey K, Verma N et al. (2009) Short report: development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 80, 336338.
  • Kumar D, Ramesh V, Verma S, Ramam M & Salotra P (2009) Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Annals of Tropical Medicine and Parasitology, 103, 727730.
  • Mondal D, Nasrin KN, Huda MM et al. (2010) Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Neglected Tropical Diseases, 4, e832.
  • Pandey K, Das VN, Singh D et al. (2012) Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. Journal of Clinical Microbiology, 50, 14781479.
  • Picado A, Singh SP, Rijal S et al. (2010) Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ, 341, c6760.
  • Rahman KM, Islam S, Rahman MW et al. (2010) Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Clinical Infectious Diseases, 50, 7376.
  • Rai RN, Kumar M, Srivastava A et al. (1989) Clinico-epidemiological profiles of post-kala-azar dermal leishmaniasis in Varanasi. Journal of Communicable Diseases, 21, 214217.
  • Singh S, Kumar J, Singh R & Dwivedi SN (2000) Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study. International Journal of Infectious Diseases, 4, 203208.
  • Stauch A, Sarkar RR, Picado A et al. (2011) Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Neglected Tropical Diseases, 5, e1405.
  • Thakur CP, Kumar A, Mitra G et al. (2008) Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian Journal of Medical Research, 128, 3844.
  • Uranw S, Ostyn B, Rijal A et al. (2011) Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Neglected Tropical Diseases, 5, e1433.
  • WHO (2010) Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010. WHO Technical Report Series. World Health Organization, Geneva.
  • Zijlstra EE, Musa AM, Khalil EA, El-Hassan IM & El-Hassan AM (2003) Post-kala-azar dermal leishmaniasis. Lancet Infectious Diseases, 3, 8798.